FOXO TECHNOLOGIES INC. Business Acquisition, Pro Forma Revenue
FOXO TECHNOLOGIES INC. (FOXO) reported Business Acquisition, Pro Forma Revenue of $3.30 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. business acquisition, pro forma revenue for the quarter ending 2026-03-31 was $3.30M.
- FOXO TECHNOLOGIES INC. business acquisition, pro forma revenue for the quarter ending 2025-12-31 was $4.43M, a 57.11% increase year-over-year.
- FOXO TECHNOLOGIES INC. business acquisition, pro forma revenue for the quarter ending 2025-09-30 was $3.69M, a 9.88% increase year-over-year.
- FOXO TECHNOLOGIES INC. business acquisition, pro forma revenue for the quarter ending 2025-06-30 was $5.43M, a 63.85% increase year-over-year.
- FOXO TECHNOLOGIES INC. business acquisition, pro forma revenue for fiscal 2025 was $16.87M, a 28.20% increase from fiscal 2024.
- FOXO TECHNOLOGIES INC. business acquisition, pro forma revenue for fiscal 2024 was $13.16M, a 29.50% decline from fiscal 2023.
- FOXO TECHNOLOGIES INC. business acquisition, pro forma revenue for fiscal 2023 was $18.67M.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 3 month as first filed | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 6 month as first filed | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 9 month as first filed | Business Acquisition, Pro Forma Revenue 12 month | Business Acquisition, Pro Forma Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $3.30M 10-Q · filed 2026-05-15 | $7.73M derived: sum of 2 quarters · filed 2026-05-15 | $11.42M derived: sum of 3 quarters · filed 2026-05-15 | $16.85M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $4.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $8.12M derived: sum of 2 quarters · filed 2026-04-15 | $13.55M derived: sum of 3 quarters · filed 2026-08-14 | $16.87M 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | $3.69M 10-Q · filed 2025-11-10 | $9.12M derived: sum of 2 quarters · filed 2026-08-14 | $12.44M 10-Q · filed 2025-11-10 | |||||
| 2025-06-30 | $5.43M 10-Q · filed 2026-08-14 | $8.75M 10-Q · filed 2026-08-14 | ||||||
| 2024-12-31 | $2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $6.18M derived: sum of 2 quarters · filed 2026-04-15 | $9.49M derived: sum of 3 quarters · filed 2026-04-15 | $13.16M 10-K · filed 2026-04-15 | $12.06M 10-K · filed 2025-04-15 | |||
| 2024-09-30 | $3.36M 10-Q · filed 2025-11-10 | $3.04M 10-Q · filed 2024-11-19 | $6.67M derived: sum of 2 quarters · filed 2025-11-10 | $10.34M 10-Q · filed 2025-11-10 | $9.71M 10-Q · filed 2024-11-19 | $13.99M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | $3.31M 10-Q · filed 2025-08-19 | $137.00K 10-Q · filed 2024-08-19 | $6.70M 10-Q · filed 2025-08-19 | $316.00K 10-Q · filed 2024-08-19 | $10.63M derived: sum of 3 quarters · filed 2025-08-19 | $14.14M derived: sum of 4 quarters · filed 2025-08-19 | ||
| 2024-03-31 | $3.38M 10-Q/A · filed 2025-08-19 | $179.00K 10-Q · filed 2024-06-28 | $7.32M derived: sum of 2 quarters · filed 2025-08-19 | $10.83M derived: sum of 3 quarters · filed 2025-08-19 | $10.84M derived: sum of 4 quarters · filed 2025-08-19 | |||
| 2023-12-31 | $3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $7.44M derived: sum of 2 quarters · filed 2025-04-15 | $7.45M derived: sum of 3 quarters · filed 2025-04-15 | $18.67M 10-K · filed 2025-04-15 | ||||
| 2023-09-30 | $3.51M 10-Q · filed 2024-11-19 | $3.52M derived: sum of 2 quarters · filed 2024-11-19 | $14.73M 10-Q · filed 2024-11-19 | |||||
| 2023-06-30 | $12.00K 10-Q · filed 2024-08-19 | $25.00K 10-Q · filed 2024-08-19 | ||||||
| 2023-03-31 | $13.00K 10-Q · filed 2024-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |